NCT02092870

Adipose Derived Regenerative Cellular Therapy of Chronic Wounds

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 25 (actual)
• Sponsor: Tower Outpatient Surgical Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Our study aims to explore the effects of Adipose Derived Stem Cells (ASCs) on chronic wounds.

Detailed description

In an attempt to explore the contribution of Adipose Derived Stem Cells (ASCs) to chronic wound healing, we will investigate the effects of injecting ASCs into the periphery and debrided surfaces of chronic wounds. Our goal is to achieve healing in two months, and for the wounds to stay healed for the following two weeks.

Conditions

• Diabetic Foot
• Venous Ulcer
• Pressure Ulcer

Interventions

Type	Name	Description
DRUG	Adipose derived stem cells	ASCs harvested from autologous lipoaspirate

Timeline

• Start date: 2013-09-01
• Primary completion: 2015-09-01
• Completion: 2019-09-09
• First posted: 2014-03-20
• Last updated: 2019-09-11

Locations

1 site across 1 country: United States